Found: 7
Select item for more details and to access through your institution.
Exposure–response characterisation of tildrakizumab in chronic plaque psoriasis: Pooled analysis of 3 randomised controlled trials.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 9, p. 1795, doi. 10.1111/bcp.14280
- By:
- Publication type:
- Article
An Integrated Model for the Glucose-Insulin System.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2010, v. 106, n. 3, p. 189, doi. 10.1111/j.1742-7843.2009.00510.x
- By:
- Publication type:
- Article
Population pharmacokinetic analyses for belzutifan to inform dosing considerations and labeling.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 10, p. 1499, doi. 10.1002/psp4.13028
- By:
- Publication type:
- Article
Identification of the Mechanism of Action of a Glucokinase Activator From Oral Glucose Tolerance Test Data in Type 2 Diabetic Patients Based on an Integrated Glucose-Insulin Model.
- Published in:
- Journal of Clinical Pharmacology, 2012, v. 52, n. 12, p. 1861, doi. 10.1177/0091270011422231
- By:
- Publication type:
- Article
Modeling of 24-Hour Glucose and Insulin Profiles of Patients With Type 2 Diabetes.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 2, p. 153, doi. 10.1177/0091270010362536
- By:
- Publication type:
- Article
An Integrated Model for Glucose and Insulin Regulation in Healthy Volunteers and Type 2 Diabetic Patients Following Intravenous Glucose Provocations.
- Published in:
- Journal of Clinical Pharmacology, 2007, v. 47, n. 9, p. 1159, doi. 10.1177/0091270007304457
- By:
- Publication type:
- Article
Exposure–Response Analyses for Belzutifan to Inform Dosing Considerations and Labeling.
- Published in:
- Journal of Clinical Pharmacology, 2024, v. 64, n. 10, p. 1246, doi. 10.1002/jcph.2459
- By:
- Publication type:
- Article